Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2006 3
2007 2
2008 5
2009 3
2010 3
2011 2
2012 2
2013 5
2014 3
2015 5
2016 6
2017 8
2018 6
2019 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy.
Triulzi T, Forte L, Regondi V, Di Modica M, Ghirelli C, Carcangiu ML, Sfondrini L, Balsari A, Tagliabue E. Triulzi T, et al. Among authors: carcangiu ml. Oncoimmunology. 2018 Sep 21;8(1):e1512942. doi: 10.1080/2162402X.2018.1512942. eCollection 2019. Oncoimmunology. 2018. PMID: 30546951 Free PMC article.
Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth.
Rea K, Roggiani F, De Cecco L, Raspagliesi F, Carcangiu ML, Nair-Menon J, Bagnoli M, Bortolomai I, Mezzanzanica D, Canevari S, Kourtidis A, Anastasiadis PZ, Tomassetti A. Rea K, et al. Among authors: carcangiu ml. J Exp Clin Cancer Res. 2018 Jul 11;37(1):146. doi: 10.1186/s13046-018-0796-1. J Exp Clin Cancer Res. 2018. PMID: 29996940 Free PMC article.
Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients.
Romeo P, Colombo C, Granata R, Calareso G, Gualeni AV, Dugo M, De Cecco L, Rizzetti MG, Zanframundo A, Aiello A, Carcangiu ML, Gloghini A, Ferrero S, Licitra L, Greco A, Fugazzola L, Locati LD, Borrello MG. Romeo P, et al. Among authors: carcangiu ml. Endocr Relat Cancer. 2018 Mar;25(3):217-231. doi: 10.1530/ERC-17-0389. Epub 2018 Jan 3. Endocr Relat Cancer. 2018. PMID: 29298817 Free article. Clinical Trial.
Ten-year results of applying an original scoring system for addressing adjuvant therapy use after breast-conserving surgery for ductal carcinoma in situ of the breast.
Gennaro M, De Santis MC, Mariani L, Lo Vullo S, Cappelletti V, Agresti R, Cortinovis U, Paolini B, Di Cosimo S, Carcangiu ML, Daidone MG, Lozza L. Gennaro M, et al. Among authors: carcangiu ml. Breast. 2017 Oct;35:63-68. doi: 10.1016/j.breast.2017.06.010. Epub 2017 Jun 23. Breast. 2017. PMID: 28651115
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Bogani G, Tagliabue E, Signorelli M, Chiappa V, Carcangiu ML, Paolini B, Casarin J, Scaffa C, Gennaro M, Martinelli F, Borghi C, Ditto A, Lorusso D, Raspagliesi F. Bogani G, et al. Among authors: carcangiu ml. J Minim Invasive Gynecol. 2017 Jul-Aug;24(5):837-842. doi: 10.1016/j.jmig.2017.04.017. Epub 2017 May 4. J Minim Invasive Gynecol. 2017. PMID: 28479170
Involvement of AF1q/MLLT11 in the progression of ovarian cancer.
Tiberio P, Lozneanu L, Angeloni V, Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D, Raspagliesi F, Pala V, Daidone MG, Appierto V. Tiberio P, et al. Among authors: carcangiu ml. Oncotarget. 2017 Apr 4;8(14):23246-23264. doi: 10.18632/oncotarget.15574. Oncotarget. 2017. PMID: 28423573 Free PMC article.
Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.
Azzollini J, Pesenti C, Ferrari L, Fontana L, Calvello M, Peissel B, Portera G, Tabano S, Carcangiu ML, Riva P, Miozzo M, Manoukian S. Azzollini J, et al. Among authors: carcangiu ml. PLoS One. 2017 Feb 15;12(2):e0171663. doi: 10.1371/journal.pone.0171663. eCollection 2017. PLoS One. 2017. PMID: 28199346 Free PMC article.
50 results